Condition: Spinal Cord Injury · Sponsor: ABLE Human Motion S.L.
The goal of this clinical trial is to to confirm the safety and performance of the ABLE Daily to perform ambulatory functions in home and community settings for people with spinal cord injury. The experimental period will cover the training period with the ABLE Daily exoskeleton (3 weeks of use at the investigational site with a total of 9 sessions) and the home period (12 weeks of personal use at home and community environments).
This description comes directly from the study's public registry record.
Noel Keijsers · + 31 6 44244217 · n.keijsers@maartenskliniek.nl
Daphne Oosterling · d.oosterling@maartenskliniek.nl
Always discuss trial participation with your own doctor first.
| Sint Maartenskliniek | Hengstdal, Ubbergen, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07062575